You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

Congress Must Protect Patient Safety and Promote Innovation in Considering Follow-on Biologics Pathway

BIO Submits Letter to Congress Detailing Concerns Regarding Clinton-Schumer Legislation Urges Congress to Consider Any Action on Follow-Ons Independent of PDUFA

Read the letter (1.2 MB PDF)